Literature DB >> 77863

Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.

M Gramse, C Bingenheimer, W Schmidt, R Egbring, K Havemann.   

Abstract

We investigated the effect of elastase-like neutral protease isolated from human granolocytes on human fibrinogen. Dependent on enzyme concentration and time of incubation, the elastase-like protease induced a progressive degradation of fibrinogen. Analysis of the remaining polypeptide chains showed a high susceptibility of the Aalpha- and low susceptibility of the gamma-chain of fibrinogen towards the proteolytic action of the enzyme. The split products were characterized by polyacrylamide gel electrophoresis and two-dimensional immunoelectrophoresis. They showed antigenic determinants of fibrinogen and of plasmin-induced proteolysis products D and E. The cleavage fragments isolated by gel chromatography had distinct molecular weights. Coagulability of fibrinogen by thrombin was inhibited according to the concentration of the protease and the time of incubation. Split products of fibrinogen with higher molecular weight prolonged the coagulation time of native fibrinogen, whereas low molecular weight fragments were ineffective.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77863      PMCID: PMC372619          DOI: 10.1172/JCI109001

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Chymotrypsin-like neutral protease from lysosomes of human polymorphonuclear leukocytes.

Authors:  W Schmidt; K Havemann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-05

2.  [LEUKOCYTIC FIBRINOLYSIS].

Authors:  O CAVIEZEL; M VOLLERY; A VANNOTTI
Journal:  Schweiz Med Wochenschr       Date:  1964-07-18

3.  LEUKOCYTES AND THROMBOSIS.

Authors:  R L HENRY
Journal:  Thromb Diath Haemorrh       Date:  1965-03-15

4.  Proteases of human leukocytes.

Authors:  L A MOUNTER; W ATIYEH
Journal:  Blood       Date:  1960-01       Impact factor: 22.113

5.  Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors.

Authors:  W Schmidt; R Egbring; K Havemann
Journal:  Thromb Res       Date:  1975-04       Impact factor: 3.944

6.  Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen.

Authors:  A B Kay; D S Pepper; M R Ewart
Journal:  Nat New Biol       Date:  1973-05-09

7.  An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

8.  Unique pattern of fibrinogen cleavage by human leukocyte proteases.

Authors:  S B Bilezikian; H L Nossel
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

9.  Neutral leucocyte proteases and elastase inhibited by plasma alpha 1 -antitrypsin.

Authors:  K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1971-11       Impact factor: 1.713

10.  Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects.

Authors:  R Egbring; W Schmidt; G Fuchs; K Havemann
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

View more
  16 in total

1.  Circulating human leucocyte elastase in patients with inflammatory bowel disease.

Authors:  E O Adeyemi; S Neumann; V S Chadwick; H J Hodgson; M B Pepys
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

2.  The role of elastases in the development of emphysema.

Authors:  Charles Kuhn; Robert M Senior
Journal:  Lung       Date:  1978-12       Impact factor: 2.584

3.  Fibrinogenolysis by a neutrophil membrane protease generates an A alpha 1-21 fragment.

Authors:  S L Kelly; S A Adams; S C Robson; R E Kirsch; E G Shephard
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

Review 4.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

Authors:  E F Plow
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

6.  Proteoglycans, proteases, chemotaxis, and aggregation of inflammatory, cells.

Authors:  W S Lynn; C Mukherjee
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Plasma and synovial fluid levels of granulocytal elastase-alpha-1-protease inhibitor complex in patients with rheumatoid arthritis.

Authors:  K Kuramitsu; A Yoshida
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  Cleavage of fibrinogen by the human neutrophil neutral peptide-generating protease.

Authors:  B U Wintroub; J S Coblyn; C E Kaempfer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Circulating human leucocyte elastase in rheumatoid arthritis.

Authors:  E O Adeyemi; R G Hull; V S Chadwick; G R Hughes; H J Hodgson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

10.  Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency.

Authors:  J I Weitz; S L Landman; K A Crowley; S Birken; F J Morgan
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.